MBL

Anti-CRELD1 (Human) mAb

Product Code:
 
MBL-W074-3
Product Group:
 
Primary Antibodies
Supplier:
 
MBL
Host Type:
 
Mouse
Antibody Isotype:
 
IgG2a κ
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
2D1E12I
Regulatory Status:
 
RUO
Target Species:
 
Human
Application:
 
Flow Cytometry
Shipping:
 
4°C
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
MBL-W074-3100 ul£345.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Applications:
FCM - 1-10 ug/mL
Background:
Cysteine-rich with EGF-like domain protein 1 (CRELD1) is a multi-pass membrane protein and belongs to the CRELD family. CRELD1 is characterized by epidermal growth factor-like repeats with cysteine-rich domains. It may function as a cell adhesion molecule. CRELD1 mRNA is highly expressed in the fetal lung, liver, and kidney, and also expressed in the adult heart, brain, and skeletal muscle. Missense mutations in the CRELD1 gene are associated with a heart defect called the atrioventricular septal defect.
Formulation:
1 mg/mL in PBS/50% glycerol, pH 7.2
Gene IDs:
Human: 78987
Immunogen Translated:
Human CRELD1 expressed Ba/F3 transfectants generated from SST-REX (signal sequence trap by retrovirus-mediated expression screening).
Reactivity:
This antibody reacts with human CRELD1 on Flow cytometry.
Source:
This antibody was purified from hybridoma culture supernatant by Protein A affinity column chromatography.
Target:
CRELD1 (Human)

Documents

References

1) Robinson, S. W., et al., Am. J. Hum. Genet. 72, 1047-1052 (2003) 2) Rupp, P. A., et al., Gene 293, 47-57 (2002) 3) Kojima, T. and Kitamura,T., Nat. Biotechnol. 17, 487-490 (1999)